Liaoning's Medical Device Innovation Service Guide: Scope, Access and Response Times
Liaoning issues a trial guide for innovation support
The Liaoning Provincial Medical Products Administration has issued its trial Medical Device Innovation Service Guide, effective upon publication. The guide sets out consultation, application support and coordination services in Liaoning for eligible medical device products. It does not announce a change to the legal conditions or statutory timelines for device registration approval.
Which projects are covered?
Covered cases include innovative devices recognized at the national or Liaoning level, devices within Liaoning's priority review scope for Class II products, already marketed Class II devices from other provinces or overseas to be registered and manufactured in Liaoning, and Class III device registrations. Products outside the guide's scope follow the ordinary consultation process. Liaoning recognized Class II innovative devices, products already included in its Class II priority review program, and confirmed cases of already marketed products to be registered and manufactured in Liaoning are included in the service scope automatically, without a separate request from the company. Companies should verify the applicable conditions for their product and project stage; an “innovative” label alone does not establish eligibility.
What changes for companies using the service?
The guide identifies access channels and response standards: companies may request support by telephone, email or the Liaoning authority's online consultation channel. General inquiries are answered within one working day. For innovative and priority products, the guide sets a five-working-day target for technical pre-review of registration dossiers. For other devices in the green channel, its target for pre-review of a complete dossier is 30 working days. The attached service list also describes pre-submission dossier checks, preliminary classification consultations and advice on clinical evaluation pathways, with the intended users and access methods for each. These are consultation and pre-review service targets; they do not change statutory review or approval timelines for registration applications.
Impact on Liaoning projects and practical steps
For companies preparing relevant registrations, manufacturing activities or submissions in Liaoning, the guide provides clearer access to support before filing. Projects outside its scope may still use the ordinary consultation process. Regulix® recommends checking the device class, innovation or priority review status, and any conditions for registration and manufacturing in Liaoning before confirming the relevant service and dossier pre-review route through the channels listed in the attachment. When preparing a formal application, companies should distinguish preliminary service advice from statutory registration review and should not treat a service target as a promise of approval.
Related application support
Regulix® can assist with device classification and registration pathway assessments, dossier preparation and compliance review, helping companies clarify eligibility and documentation issues before using Liaoning's service channels. Consultation and pre-review do not replace a formal registration application or guarantee approval.
